Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Peripheral monocyte–derived cells counter amyloid plaque pathogenesis in a mouse model of Alzheimer’s disease
Ping Yan, … , Jin-Moo Lee, Abhinav Diwan
Ping Yan, … , Jin-Moo Lee, Abhinav Diwan
Published May 5, 2022
Citation Information: J Clin Invest. 2022;132(11):e152565. https://doi.org/10.1172/JCI152565.
View: Text | PDF
Research Article Neuroscience

Peripheral monocyte–derived cells counter amyloid plaque pathogenesis in a mouse model of Alzheimer’s disease

  • Text
  • PDF
Abstract

Microglia, the parenchymal tissue macrophages in the brain, surround amyloid plaques in brains of individuals with Alzheimer’s disease (AD) but are ineffective at clearing amyloid to mitigate disease progression. Recent studies in mice indicate that microglia are derived exclusively from primitive yolk sac hematopoiesis and self-renew without contribution from ontogenically distinct monocytes/macrophages of definitive adult hematopoietic origin. Using a genetic fate-mapping approach to label cells of definitive hematopoietic origin throughout life span, we discovered that circulating monocytes contribute 6% of plaque-associated macrophages in aged AD mice. Moreover, peripheral monocytes contributed to a higher fraction of macrophages in the choroid plexus, meninges, and perivascular spaces of aged AD mice versus WT control mice, indicating enrichment at potential sites for entry into the brain parenchyma. Splenectomy, which markedly reduced circulating Ly6Chi monocytes, also reduced abundance of plaque-associated macrophages of definitive hematopoietic origin, resulting in increased amyloid plaque load. Together, these results indicate that peripherally derived monocytes invade the brain parenchyma, targeting amyloid plaques to reduce plaque load.

Authors

Ping Yan, Ki-Wook Kim, Qingli Xiao, Xiucui Ma, Leah R. Czerniewski, Haiyan Liu, David R. Rawnsley, Yan Yan, Gwendalyn J. Randolph, Slava Epelman, Jin-Moo Lee, Abhinav Diwan

×

Figure 3

Fate mapping demonstrates peripheral monocyte–derived cells adjacent to amyloid plaques in the brain parenchyma of APP/PS1 mice.

Options: View larger image (or click on image) Download as PowerPoint
Fate mapping demonstrates peripheral monocyte–derived cells adjacent to ...
(A and B) Representative cortical sections from aged WTmTmG;Flt3-Cre (n = 5) and APP/PS1mTmG;Flt3-Cre mice (n = 8) demonstrating that GFP+ cells (A) are not detected in the WT brain parenchyma and (B) are seen adjacent to X-34–stained amyloid plaques in APP/PS1 mice. White arrows point to a GFP+ cell in the perivascular space in WTmTmG;Flt3-Cre brain in A and to GFP+ cells adjacent to X34-labeled amyloid plaques in B. Scale bar: 250 μm. (C–N) Representative cortical sections from aged APP/PS1mTmG;Flt3-Cre mice demonstrating X-34–stained plaque (with DAPI-stained nuclei as shown in C, G, and K; plaque is outlined) (D, H, and L) with GFP expression, (E and F) which colocalizes with a microglial marker, Iba-1; (I and J) with CD11b, a marker for activated microglia; and (M and N) with CD68, a marker for phagocytic cells also present on microglia. Scale bar: 10 μm. Dotted lines outline amyloid plaques. (O) A GFP+ cell adjacent to amyloid plaque demonstrating colocalization with Aβ (red). Dotted lines outline amyloid plaques. Scale bar: 5 μm. (P–R) Correlation between the density of GFP+ cells expressing (P) Iba-1, (Q) CD11b, and (R) CD68 in the cortex and the amyloid plaque load detected by X-34 staining. Pearson’s coefficient of correlation, R2 is shown with P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts